Task: Answer the multiple-choice question.
Question: Which drug exhibits a 5.236% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a Cc1ccc2ccc[n+](Cc3ccccc3)c2c1.[Br-]
b N#C/C(=C\c1cc2ccccc2nc1N1CCCCC1)C(N)=O
c COc1ccc(Cl)cc1C(=O)NNC(=O)CSc1nnc2ccccn12
d COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl
e COc1ccc(-c2nn(CCC#N)cc2C(=O)Nc2ccccc2Br)cc1[N+](=O)[O-]
Answer: c. COc1ccc(Cl)cc1C(=O)NNC(=O)CSc1nnc2ccccn12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cl)cc1C(=O)NNC(=O)CSc1nnc2ccccn12
COc1ccc(Cl)cc1C(=O)NNC(=O)CSc1nnc2ccccn12
5-chloro-2-methoxy-N'-[2-([1,2,4]triazolo[4,3-a]pyridin-3-ylsulfanyl)acetyl]benzohydrazide